Exploring the world of ‘implementation science’ – Melvin ‘Skip’ Olson

Return to the Spotlight: rare diseases and innovative therapies programme Learning objectives  Understanding efficacy issues in drug market access How barriers can get in the way of innovations being 'implemented' properly into the healthcare system Understanding what implementation research is and its framework Discussing what implementation could look like in pharma in the future Speaker biography Skip Olson is currently the Global Head of Integrated Evidence Strategy and Innovation at Novartis (Basel, Switzerland). As such, he is responsible for promoting the very best in research methodology and applications of real-world evidence (RWE), and other evidence, across all therapeutic areas and...